Pro Pharmaceuticals Group to Attend CPhI Frankfurt 2025

We are pleased to announce that Pro Pharmaceuticals Group will be attending CPhI Worldwide 2025 in Frankfurt, Germany, from 28–30 October 2025.

This will be our ninth consecutive year at the event, and Sandip Manku (Managing Director) and Lukasz Nowaczek (Head of EU Operations) will be present to represent the company.

Our Focus at CPhI 2025

At this year’s event, our discussions will centre on:

• Product registrations for the Australian market, where we have direct accounts with hospitals and are actively supplying under the Special Access Scheme and Section 19A.

• Comparator (RLD) supplies to manufacturers and CROs, supporting clinical trials and development worldwide.

• Meetings with suppliers and customers to expand partnerships and strengthen our global network.

With a strong base in Australia and growing international reach, Pro Pharmaceuticals Group remains committed to accelerating access, supporting clinical research, and ensuring continuity of supply across the pharmaceutical value chain.

Meet Sandip and Lukasz in Frankfurt, 28–30 October 2025 – we look forward to connecting with you.

Our appointment slots are filling quickly. If you would like to meet, please contact us in advance and provide specific information on the value and focus of the discussion so we can ensure the meeting is productive.

Learn more about the event: CPhI Worldwide 2025